Free Access to Cancer Research Services - canSERV 1st Call for Proposals
One document
more
Stories about Krankheit
Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris
One documentmoreType 1 Diabetes Awareness Campaign - K1DS ARE HEROES - started
moreBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
moreFlu tests from R-Biopharm also detect new virus variants
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
more
Klinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
moreType 1 diabetes: New findings on the development of the autoimmune disease in children
moreSwitching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signaling
moreLandscape of molecular contacts: How the coronavirus SARS-CoV-2 communicates with human cells
moreEfficient AI technology for MRI data analysis
more- 2
Vitamin K prevents cell death: a new function for a long-known molecule
more
R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
moreR-Biopharm announces test to detect monkeypox virus
moreInnovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio
One documentmoreWhy is it advisable to use lemon vitamin C during the winter?
more- 2
Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomats
more ALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERS
more
- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
more CPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
more- 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
One documentmore New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
more- 6
Press Release MAHLE Covid-19 worldwide vaccination initiatives
more ZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospital
more
- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
One documentmore - 3
Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access
more - 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore Gastrulation research reveals novel details about embryonic development
moreNOMOS Glashütte/SA Roland Schwertner KG
3Watches that help those who help
moreDAAD Annual Report 2020: Lively exchange in difficult times
more
Previous12345Next